Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymus Tumors”

166 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 166 results

Testing effectiveness (Phase 2)Study completedNCT00990535
What this trial is testing

High Dose Somatostatin Analogues in Neuroendocrine Tumors

Who this might be right for
Respiratory Tract NeoplasmsThymic NeoplasmsPancreatic Neoplasms+2 more
Federico II University 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750952
What this trial is testing

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial

Who this might be right for
Relapsed or Metastatic Thymic CancerFirst-line Treatment
Sun Yat-sen University 24
Not applicableStudy completedNCT04662645
What this trial is testing

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Who this might be right for
CaregiverMalignant Pleural NeoplasmMetastatic Thymic Carcinoma+9 more
Ohio State University Comprehensive Cancer Center 68
Not applicableStudy completedNCT03078699
What this trial is testing

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment

Who this might be right for
ThymomaThymic Tumor
Third Military Medical University 32
Not applicableEnded earlyNCT04072393
What this trial is testing

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Who this might be right for
Lung CancerEsophageal CancerThoracic Cancer+6 more
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324629
What this trial is testing

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 30
Not applicableStudy completedNCT02636556
What this trial is testing

Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

Who this might be right for
Thymoma and Thymic Carcinoma
Fudan University 56
Not applicableLooking for participantsNCT01950572
What this trial is testing

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Who this might be right for
MesotheliomaThymomaPancreatic Neoplasms+2 more
National Cancer Institute (NCI) 1,000
Not applicableStudy completedNCT07179341
What this trial is testing

Survival Nomogram for Patients With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Weijie Ye 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT03921671
What this trial is testing

Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)

Who this might be right for
Thymic CarcinomaThymoma
Claudia Proto 60
Testing effectiveness (Phase 2)Study completedNCT03694002
What this trial is testing

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Thymic CarcinomaMetastatic Thymic CarcinomaRecurrent Thymic Carcinoma+1 more
SWOG Cancer Research Network 21
Testing effectiveness (Phase 2)WithdrawnNCT01610544
What this trial is testing

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Who this might be right for
Carcinoma, Non-Small-Cell LungThymus Neoplasms
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT05682742
What this trial is testing

Clinical Investigation of the da Vinci Surgical System

Who this might be right for
ThymomaMediastinal TumorGynecologic Disease+7 more
Intuitive Surgical 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03076554
What this trial is testing

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT02021942
What this trial is testing

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

Who this might be right for
Primary Inoperable ThymomaLocal Recurrent Thymoma
Prof. Dr. Berthold Schalke 16
Testing effectiveness (Phase 2)Looking for participantsNCT05683886
What this trial is testing

KC1036 in Patients with Advanced Thymic Tumors

Who this might be right for
Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT02936323
What this trial is testing

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

Who this might be right for
Neuroendocrine TumorsCarcinoma, Small Cell LungNeuroendocrine Carcinoma
Tarveda Therapeutics 89
Not applicableStudy completedNCT05255965
What this trial is testing

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Who this might be right for
Thymoma
Shanghai Zhongshan Hospital 310
Not applicableActive Not RecruitingNCT05150210
What this trial is testing

SP Thoracic IDE Study

Who this might be right for
Primary Lung CancerBenign Lung DiseaseThymoma+1 more
Intuitive Surgical 32
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Load More Results